Laboratory Products
Automation Solutions and Services to Aid Critical Coronavirus (COVID-19)Testing
Mar 25 2020
Hamilton Company announces multiple automation-related initiatives to aid healthcare workers and researchers as they battle the coronavirus (COVID-19) pandemic.
Two new automated assay ready workstations, based on the Company’s Microlab® STARlet liquid handling workstation, facilitate rapid, high-throughput diagnostic and research-based testing of SARS-CoV-2, the coronavirus that causes the novel COVID-19. The MagEx STARlet assay ready workstation enables high-throughput magnetic bead-based RNA extraction of biological samples. The PCR Prep STARlet assay ready workstation is pre-configured and qualified to automate high-throughput pre-PCR sample setup using the latest Centers for Disease Control and Prevention (CDC) protocols
Both assay ready workstations are designed to work with any provider’s assay chemistry, including those intended for qualitative detection of the coronavirus. Once the coronavirus situation stabilises, the assay ready workstations may be repurposed to provide multi-faceted efficiencies to any number of assay workflows.
The MagEx STARlet and PCR Prep STARlet add to the existing portfolio of assay ready workstations specifically designed to automate molecular biology workflows and viral testing. Other workstations in the family include the NIMBUS® Presto, which integrates the Thermo Scientific™ King Fisher™ Presto purification system for hands-free, high throughput nucleic acid extraction, and the RT STARlet, which is a walkaway solution for real-time PCR sample preparation and detection.
Finally, the Company will prioritise all incoming orders related to the fight against the coronavirus. Rapid delivery of hardware, software, accessories, and consumables is available from the Company’s manufacturing locations in Reno, Nevada, USA and Bonaduz, Switzerland. Fast-tracked order processing and delivery are meant to reduce or eliminate testing delays due to delivery lag times throughout the United States and Europe, where coronavirus testing demands are particularly high.
"Our support of the healthcare community and researchers working to identify, treat, and contain the coronaviruses is our prime priority," said Steve Hamilton, President and CEO of Hamilton Company.
More information online
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark